Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

JY, Reginster; E, Seeman; Vernejoul MC, De; S, Adami; J, Compston; C, Phenekos; JP, Devogelaer; MD, Curiel; A, Sawicki; S, Goemaere; OH, Sorensen; D, Felsenberg; PJ, Meunier

doi:10.1210/jc.2004-1774

Public

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Shared by NobleBlocks on Feb 22, 2005 • 12:00 AM UTC

Authors:

Reginster JY

Seeman E

De Vernejoul MC

Abstract

Background Strontium ranelate, a new oral drug shown to reduce vertebral fracture risk in postmenopausal women with osteoporosis, was studied in the Treatment of Peripheral Osteoporosis (TROPOS) study to assess its efficacy and safety in preventing nonvertebral fractures also.Methods Strontium ranel...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!